May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

Join Drs Maureen McMahon and Michael Garshick as they discuss cardiovascular disease in patients with systemic lupus erythematosus, focusing on hidden risk and challenging clinical scenarios.

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

A Lockyer Valley town has been left in shock after a young mum’s sudden death. Laidley’s Tearra Jade Freeth, known to friends ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...

Exposing children with peanut allergy to proteins from the legume is an approved treatment to reduce the risk of allergic ...

Chair yoga improves flexibility and may be easier on your knees and back. This article lists yoga poses ideal for people 55 ...

The month of April is Stress Awareness Month and on that note let us learn more about the autoimmune diseases that can get ...

Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting, taking place May 3-6 in San Diego, California. The oral and poster ...

lupus, multiple sclerosis, and non-alcoholic steatoheptatitis (NASH). But according to one of its backers Quench is unlikely to target the big indications such as RA where there are a wealth of ...